This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Cytoki Pharma Aps. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: The Innovations of Kristian Sass-Ørum
Introduction
Kristian Sass-Ørum is a notable inventor based in Bagsværd, Denmark. He has made significant contributions to the field of biotechnology, particularly through his work on interleukin-22 derivatives. With a total of three patents to his name, Sass-Ørum's innovations are paving the way for new therapeutic approaches.
Latest Patents
One of his latest patents focuses on therapeutic derivatives of interleukin-22. This invention relates to novel derivatives of interleukin-22 (IL-22), particularly those comprising a fatty acid covalently attached to an IL-22 protein, and their use in therapy. This innovative approach has the potential to enhance therapeutic efficacy in various medical applications.
Career Highlights
Throughout his career, Kristian has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Cytoki Pharma ApS and Novo Nordisk A/S. His experience in these organizations has contributed to his expertise and success as an inventor.
Collaborations
Some of his notable coworkers include Rasmus Jørgensen and Thomas Hoeg-Jensen. Their collaborative efforts have likely played a role in advancing the research and development of innovative therapies.
Conclusion
Kristian Sass-Ørum's work exemplifies the impact of innovation in biotechnology. His patents and collaborations highlight his commitment to advancing therapeutic solutions. His contributions are significant in the ongoing quest for improved medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile